We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Is Align Technology (ALGN) Stock Outpacing Its Medical Peers This Year?
Read MoreHide Full Article
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has Align Technology (ALGN - Free Report) been one of those stocks this year? Let's take a closer look at the stock's year-to-date performance to find out.
Align Technology is a member of our Medical group, which includes 763 different companies and currently sits at #10 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.
The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. ALGN is currently sporting a Zacks Rank of #1 (Strong Buy).
The Zacks Consensus Estimate for ALGN's full-year earnings has moved 4.50% higher within the past quarter. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.
According to our latest data, ALGN has moved about 46.80% on a year-to-date basis. Meanwhile, stocks in the Medical group have lost about 1.77% on average. This means that Align Technology is outperforming the sector as a whole this year.
Looking more specifically, ALGN belongs to the Medical - Dental Supplies industry, a group that includes 23 individual stocks and currently sits at #110 in the Zacks Industry Rank. On average, stocks in this group have gained 0.18% this year, meaning that ALGN is performing better in terms of year-to-date returns.
ALGN will likely be looking to continue its solid performance, so investors interested Medical stocks should continue to pay close attention to the company.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Is Align Technology (ALGN) Stock Outpacing Its Medical Peers This Year?
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has Align Technology (ALGN - Free Report) been one of those stocks this year? Let's take a closer look at the stock's year-to-date performance to find out.
Align Technology is a member of our Medical group, which includes 763 different companies and currently sits at #10 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.
The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. ALGN is currently sporting a Zacks Rank of #1 (Strong Buy).
The Zacks Consensus Estimate for ALGN's full-year earnings has moved 4.50% higher within the past quarter. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.
According to our latest data, ALGN has moved about 46.80% on a year-to-date basis. Meanwhile, stocks in the Medical group have lost about 1.77% on average. This means that Align Technology is outperforming the sector as a whole this year.
Looking more specifically, ALGN belongs to the Medical - Dental Supplies industry, a group that includes 23 individual stocks and currently sits at #110 in the Zacks Industry Rank. On average, stocks in this group have gained 0.18% this year, meaning that ALGN is performing better in terms of year-to-date returns.
ALGN will likely be looking to continue its solid performance, so investors interested Medical stocks should continue to pay close attention to the company.